Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Syringe Needle device with Separate Aspiration Channel: The participants requiring injections (other than intravascular) for drugs or vaccines, nerve blocks, plexus blocks, infiltration
Sponsors
B J Medical College and Civil Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patient participants: 1. Patients who are non-critical and need to receive injections (other than intravenous) for drugs/vaccines, nerve blocks, plexus blocks, infiltration anaesthesia, or depot injections. 2. The individuals capable and willing to provide informed consent for participation in the clinical trial HCP participants: Licensed Healthcare care professionals (HCPs: registered nurses, certified nursing assistants, and registered medical practitioners) with at least six months of experience administering injections are eligible to participate in the study as intended users of Aspiel® Syringe and Hypodermic Syringe with Needle.
Exclusion criteria
Exclusion criteria: Patient Participants: 1. Patients who are allergic to the intended injection drug 2. Patients who require administration of opaque drugs 3. Patients who have a mental illness 4. Patients who are unable to comprehend the protocol or provide informed consent 5. Patients already taking pain medications. HCP participants: HCPs with any previous contact with the Aspiel® Syringe will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ease of injection and ease of aspiration as reported by healthcare professionals and extent of pain as reported by patientsTimepoint: During each injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive or negative aspirate before injectingTimepoint: During each injection procedure | — |
Countries
India
Contacts
Public ContactDr Prujal Parekh
Sal Institute of Medical Sciences, Ahmedabad
Outcome results
None listed